On the following pages, I have attached selected financial ratios for Abbott Laboratories and Pfizer, Inc., respectively.   Required Using the relevant ratios from the attached schedules, please answer the following questions.  To do this you should consider the 3-year trend, i.e. improving, declining, or remaining stable, and the absolute metrics presented.   In answering each question, please identify the relevant ratio(s) from the attached schedules supporting your answer.   Over the 3-year period presented, which company is most effective at collecting cash on its accounts receivable? Using the ratios provided, please explain/support your answer.   Over the 3-year period presented, which company generated the highest return on its owners’ investment? Using the ratios provided, please explain/support your answer.   Based on the 3-year performance, which company has the riskiest debt profile? Using the ratios provided, please explain/support your answer.   Based on the 3-year performance, which company is in the best position to meet its current obligations and have assets available to meet unexpected opportunities and expenses? Using the ratios provided, please explain/support your answer.   If you were a bank lending officer and each of these companies applied for a $1 billion office complex construction loan (i.e. to be repaid in 25 years with interest payments beginning immediately after funding begins), which company would you be more likely to lend? Using the ratios provided, please explain/support your answer.   If you were a financial analyst for a global investment company or pension fund, which company would you assign the higher investment recommendation? Using the ratios provided, please explain/support your answer.             Abbott Laboratories (NYS: ABT)         Profitability Ratios 12/31/2019 12/31/2018 12/31/2017 ROA % (Net) 5.46 3.3 0.74 ROE % (Net) 11.97 7.71 1.85 EBITDA Margin % 24.03 22.47 22.02         Liquidity Ratios 12/31/2019 12/31/2018 12/31/2017 Quick Ratio 0.88 1.03 1.67 Current Ratio 1.44 1.62 2.26         Debt Management 12/31/2019 12/31/2018 12/31/2017 LT Debt to Equity 0.54 0.63 0.88 Total Debt to Equity 0.58 0.64 0.9 Interest Coverage 7.87 5.06 2.21         Asset Management 12/31/2019 12/31/2018 12/31/2017 Total Asset Turnover 0.47 0.43 0.42 Receivables Turnover 6.02 5.86 6.45 Inventory Turnover 3.26 3.44 4.09 Accounts Payable Turnover 10.25 11.37 15.3 Property Plant & Equip Turnover 4.09 4.03 4.12         Per Share 12/31/2019 12/31/2018 12/31/2017 Book Value per Share 17.64 17.39 17.72         Pfizer Inc. (NYS: PFE)         Profitability Ratios 12/31/2019 12/31/2018 12/31/2017 ROA % (Net) 9.96 6.73 12.41 ROE % (Net) 25.72 16.56 32.57 EBITDA Margin % 45.68 33.11 34.15         Liquidity Ratios 12/31/2019 12/31/2018 12/31/2017 Quick Ratio 0.5 0.84 0.93 Current Ratio 0.88 1.57 1.35         Debt Management 12/31/2019 12/31/2018 12/31/2017 LT Debt to Equity 0.57 0.52 0.47 Total Debt to Equity 0.83 0.66 0.61 Interest Coverage 7.67 11.78 14.61         Asset Management 12/31/2019 12/31/2018 12/31/2017 Total Asset Turnover 0.32 0.32 0.31 Receivables Turnover 6.18 6.6 6.39 Inventory Turnover 1.29 1.49 1.57 Accounts Payable Turnover 11.64 11.5 11.43 Property Plant & Equip Turnover 3.78 3.94 3.87         Per Share 12/31/2019 12/31/2018 12/31/2017 Book Value per Share 11.41 11.09 11.93

FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
icon
Related questions
Question

Problem 3

On the following pages, I have attached selected financial ratios for Abbott Laboratories and Pfizer, Inc., respectively.

 

Required

Using the relevant ratios from the attached schedules, please answer the following questions.  To do this you should consider the 3-year trend, i.e. improving, declining, or remaining stable, and the absolute metrics presented.

 

In answering each question, please identify the relevant ratio(s) from the attached schedules supporting your answer.

 

  1. Over the 3-year period presented, which company is most effective at collecting cash on its accounts receivable? Using the ratios provided, please explain/support your answer.

 

  1. Over the 3-year period presented, which company generated the highest return on its owners’ investment? Using the ratios provided, please explain/support your answer.

 

  1. Based on the 3-year performance, which company has the riskiest debt profile? Using the ratios provided, please explain/support your answer.

 

  1. Based on the 3-year performance, which company is in the best position to meet its current obligations and have assets available to meet unexpected opportunities and expenses? Using the ratios provided, please explain/support your answer.

 

  1. If you were a bank lending officer and each of these companies applied for a $1 billion office complex construction loan (i.e. to be repaid in 25 years with interest payments beginning immediately after funding begins), which company would you be more likely to lend? Using the ratios provided, please explain/support your answer.

 

  1. If you were a financial analyst for a global investment company or pension fund, which company would you assign the higher investment recommendation? Using the ratios provided, please explain/support your answer.

 

 

 

 

 

 

Abbott Laboratories (NYS: ABT)

 

 

 

 

Profitability Ratios

12/31/2019

12/31/2018

12/31/2017

ROA % (Net)

5.46

3.3

0.74

ROE % (Net)

11.97

7.71

1.85

EBITDA Margin %

24.03

22.47

22.02

 

 

 

 

Liquidity Ratios

12/31/2019

12/31/2018

12/31/2017

Quick Ratio

0.88

1.03

1.67

Current Ratio

1.44

1.62

2.26

 

 

 

 

Debt Management

12/31/2019

12/31/2018

12/31/2017

LT Debt to Equity

0.54

0.63

0.88

Total Debt to Equity

0.58

0.64

0.9

Interest Coverage

7.87

5.06

2.21

 

 

 

 

Asset Management

12/31/2019

12/31/2018

12/31/2017

Total Asset Turnover

0.47

0.43

0.42

Receivables Turnover

6.02

5.86

6.45

Inventory Turnover

3.26

3.44

4.09

Accounts Payable Turnover

10.25

11.37

15.3

Property Plant & Equip Turnover

4.09

4.03

4.12

 

 

 

 

Per Share

12/31/2019

12/31/2018

12/31/2017

Book Value per Share

17.64

17.39

17.72

 

 

 

 

Pfizer Inc. (NYS: PFE)

 

 

 

 

Profitability Ratios

12/31/2019

12/31/2018

12/31/2017

ROA % (Net)

9.96

6.73

12.41

ROE % (Net)

25.72

16.56

32.57

EBITDA Margin %

45.68

33.11

34.15

 

 

 

 

Liquidity Ratios

12/31/2019

12/31/2018

12/31/2017

Quick Ratio

0.5

0.84

0.93

Current Ratio

0.88

1.57

1.35

 

 

 

 

Debt Management

12/31/2019

12/31/2018

12/31/2017

LT Debt to Equity

0.57

0.52

0.47

Total Debt to Equity

0.83

0.66

0.61

Interest Coverage

7.67

11.78

14.61

 

 

 

 

Asset Management

12/31/2019

12/31/2018

12/31/2017

Total Asset Turnover

0.32

0.32

0.31

Receivables Turnover

6.18

6.6

6.39

Inventory Turnover

1.29

1.49

1.57

Accounts Payable Turnover

11.64

11.5

11.43

Property Plant & Equip Turnover

3.78

3.94

3.87

       

Per Share

12/31/2019

12/31/2018

12/31/2017

Book Value per Share

11.41

11.09

11.93

Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 5 steps

Blurred answer
Knowledge Booster
Ratio Analysis
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education